Cargando…
Acylhydrazones as Antifungal Agents Targeting the Synthesis of Fungal Sphingolipids
The incidence of invasive fungal infections has risen dramatically in recent decades. Current antifungal drugs are either toxic, likely to interact with other drugs, have a narrow spectrum of activity, or induce fungal resistance. Hence, there is a great need for new antifungals, possibly with novel...
Autores principales: | Lazzarini, Cristina, Haranahalli, Krupanandan, Rieger, Robert, Ananthula, Hari Krishna, Desai, Pankaj B., Ashbaugh, Alan, Linke, Michael J., Cushion, Melanie T., Ruzsicska, Bela, Haley, John, Ojima, Iwao, Del Poeta, Maurizio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923120/ https://www.ncbi.nlm.nih.gov/pubmed/29507066 http://dx.doi.org/10.1128/AAC.00156-18 |
Ejemplares similares
-
Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids
por: Mor, Visesato, et al.
Publicado: (2015) -
Erratum for Mor et al., “Identification of a New Class of Antifungals Targeting the Synthesis of Fungal Sphingolipids”
por: Mor, Visesato, et al.
Publicado: (2018) -
Antifungal Drug Development: Targeting the Fungal Sphingolipid Pathway
por: McEvoy, Kyle, et al.
Publicado: (2020) -
Efficacy of Rezafungin in Prophylactic Mouse Models of Invasive Candidiasis, Aspergillosis, and Pneumocystis Pneumonia
por: Miesel, Lynn, et al.
Publicado: (2021) -
Sphingolipids as Regulators of the Phagocytic Response to Fungal Infections
por: Bryan, Arielle M., et al.
Publicado: (2015)